Discover
SER
Serina Therapeutics, Inc.
2.25
100 x 2.10
400 x 2.14
bid
ask
+
0.03
1.35%
250 @ 07:30 PM
2.13 -0.12 (5.33%)
| Ytd | 17.80% | |
| 1y | -50.11% |
2.09
day range
2.29
1.28
52 week range
5.63
| Open | 2.20 | Prev Close | 2.22 | Low | 2.09 | High | 2.29 | Mkt Cap | 57.15M |
| Vol | 66.08K | Avg Vol | 54.89K | EPS | -1.87 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.18 | Short Ratio | 1.96 | Inst. Own | 3.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 2.38 | 200-d Avg | 2.22 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 6.78M | ||
| Research and Development Expense | 3.82M | ||
| Selling, General and Administrative Expense | 2.97M | ||
| Operating Income | -6.78M | ||
| Interest Expense | 203.00K | ||
| Net Income | -6.36M | ||
| Net Income Common Stock | -8.93M | ||
| Net Income Common Stock (USD) | -8.93M | ||
| Consolidated Income | -6.36M | ||
| Earnings per Basic Share | -0.55 | ||
| Earnings per Basic Share (USD) | -0.55 | ||
| Earnings per Diluted Share | -0.55 | ||
| Earning Before Interest & Taxes (EBIT) | -6.15M | ||
| Earning Before Interest & Taxes (USD) | -6.15M | ||
| Preferred Dividends Income Statement Impact | 2.58M | ||
| Weighted Average Shares | 16.39M | ||
| Weighted Average Shares Diluted | 16.39M | ||
| Balance Sheet | |||
| Cash and Equivalents | 23.02M | ||
| Cash and Equivalents (USD) | 23.02M | ||
| Current Assets | 25.03M | ||
| Property, Plant & Equipment Net | 759.00K | ||
| Total Assets | 25.81M | ||
| Total Debt | 3.21M | ||
| Current Liabilities | 3.76M | ||
| Debt Non-Current | 3.21M | ||
| Total Liabilities | 7.08M | ||
| Accumulated Retained Earnings (Deficit) | -76.75M | ||
| Shareholders Equity | 18.73M | ||
| Shareholders Equity (USD) | 18.73M | ||
| Assets Non-Current | 784.00K | ||
| Total Debt (USD) | 3.21M | ||
| Liabilities Non-Current | 3.32M | ||
| Trade and Non-Trade Payables | 1.86M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 69.00K | ||
| Net Cash Flow from Financing | 5.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.50M | ||
| Capital Expenditure | -28.00K | ||
| Issuance (Purchase) of Equity Shares | 5.20M | ||
| Net Cash Flow from Investing | -28.00K | ||
| Net Cash Flow from Operations | -6.68M | ||
| Effect of Exchange Rate Changes on Cash | 8.00K | ||
| Share Based Compensation | 1.05M | ||